Elsunersen

N/A

Report date: 2026/05/14 20:00:28
NME

Base Information

Drug NameElsunersen
Drug Alias NamePRAX-222
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionSodium channel protein type II alpha subunit blockers
TargetsSodium channel protein type II alpha subunit
Therapy Area/IndicationsEpilepsyBrain Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesBrazil
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPraxis Precision Medicines
China Registration ClassN/A

Develop Information

Active CompaniesPraxis Precision Medicines
Inactive CompaniesN/A
Active IndicationsEpilepsyBrain Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A